IL1RAP and non-small cell lung carcinoma: IL-1RAP was found overexpressed in NSCLC cell lines [103], and anti-IL-1RAP immunotherapy was recently successfully assessed in an NSCLC PDX preclinical [28] model, LU2503, on Balb/c mice.